https://www.selleckchem.com/pr....oducts/srt2104-gsk22
Introduction Focal therapy (FT) for localized prostate cancer (PCa) is a promising treatment strategy. Although, according to guidelines, it should be regarded as an experimental option, its introduction into clinical practice has occurred at an accelerated speed. It is, thus, crucial for Urologists to understand FT limitations and potential drawbacks that may derive from its use. Methods We performed a literature search of peer-reviewed English language articles using Pubmed and the words "focal therapy" AND "prostate cancer
Like
Comment
Share
